AstraZeneca Tagrisso gets Japanese okay for early-stage EGFR-mutated lung cancer Ruchika Sharma30 Aug 2022 9:45 AM ISTNew Delhi: AstraZeneca's Tagrisso (osimertinib) has been approved in Japan for the adjuvant treatment of patients with epidermal growth factor...
Vision Improves after giving Osimertinib in Paraneoplastic Optic Neuropathy tied to Lung Adenocarcinoma: Case study Dr Ishan Kataria13 Aug 2021 9:00 AM ISTParaneoplastic optic neuropathy (PON) is one of several tumor-related autoimmune diseases, such as cancer associated retinopathy (CAR) and...
NPPA gets Delhi HC notice on AstraZeneca plea over cancer drug Tagrisso Ruchika Sharma15 July 2021 1:28 PM ISTNew Delhi: The Delhi High Court on Monday issued notice to National Pharmaceutical Pricing Authority (NPPA) and others on AstraZeneca Pharma India's...
NPPA alleges overcharging for cancer drug Tagrisso: AstraZeneca moves Delhi HC against Rs 157 crore demand notice Medical Dialogues Team30 Jun 2021 5:02 PM ISTNew Delhi: AstraZeneca Pharma India has moved the Delhi High Court challenging a demand notice issued by the National Pharmaceutical Pricing Authority...
Osimertinib improves survival in cases of lung cancer metastasis, finds study has Dr. Nandita Mohan1 Jun 2021 9:00 AM ISTResearch reveals that patients with T790M-positive, non-small-cell lung cancer (NSCLC) and multiple central nervous system (CNS) metastases after...
Delhi HC asks NPPA to reconsider show cause issued to AstraZeneca over cancer drug Tagrisso Medical Dialogues Team16 May 2021 11:00 AM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has been directed by the Delhi High Court to reconsider and issue a fresh order to...
AstraZeneca Pharma India gets marketing nod for cancer drug Tagrisso Ruchika Sharma11 March 2021 1:21 PM ISTOsimertinib has shown to decrease the chances of cancer spreading to the brain & other distant organs.
FDA approves osimertinib for treatment of non-small cell lung cancer Hina Zahid20 Dec 2020 7:45 AM ISTThe U.S. Food and Drug Administration has approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer...
Europe recommends lung cancer drugs from AstraZeneca, Lilly savita thakur thakur19 Dec 2015 11:41 AM ISTThe European Medicines Agency said  its experts had recommended marketing approval for lung cancer drugs developed by AstraZeneca and Eli Lilly and...
FDA approves new pill for non-small cell lung cancer Meghna A Singhania15 Nov 2015 3:58 PM ISTU.S. Food and Drug Administration granted accelerated approval for an oral medication to treat patients with advanced non-small cell lung cancer...
